Psyence Biomedical annual ebitda
2023
2024
2025
2026
Psyence Biomedical EBITDA Growth & History (PBM)
Psyence Biomedical's calculated EBITDA was −$6.9M for fiscal 2026.
View full Psyence Biomedical company overviewPsyence Biomedical annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$6.9M | −$7.9M | — |
| 2025 | 2025-03-31 | $1.0M | $52.1M | — |
| 2024 | 2024-03-31 | −$51.1M | −$47.9M | — |
| 2023 | 2023-03-31 | −$3.2M | — | — |
Psyence Biomedical quarterly ebitda
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-09-30 | −$749,171 | — | — |
Psyence Biomedical ebitda trends
Between the periods ended 2023-03-31 and 2026-03-31, Psyence Biomedical's ebitda decreased from −$3.2M to −$6.9M, a change of −$3.7M. The latest reported quarter, Q2 2026, shows −$749,171.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Psyence Biomedical source filings ↗